Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Cost of Revenue (2018 - 2023)

Historic Cost of Revenue for ImmunoTech (AIM) over the last 6 years, with Q4 2023 value amounting to $12000.0.

  • ImmunoTech's Cost of Revenue changed N/A to $12000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $446000.0, marking a year-over-year change of. This contributed to the annual value of $31000.0 for FY2024, which is 2619.05% down from last year.
  • Per ImmunoTech's latest filing, its Cost of Revenue stood at $12000.0 for Q4 2023.
  • ImmunoTech's Cost of Revenue's 5-year high stood at $204000.0 during Q1 2020, with a 5-year trough of $12000.0 in Q4 2023.